IP Verse

Oxazine Derivatives And Their Use As Bace Inhibitors For The Treatment Of Neurological Disorders

Patent No. EP2456763 (titled "Oxazine Derivatives And Their Use As Bace Inhibitors For The Treatment Of Neurological Disorders") was filed by Novartis on Jul 23, 2010. The application was issued on Jan 21, 2015.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
JANSSEN PHARMACEUTICAOct 21, 2015CORNISH

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP2456763

NOVARTIS
Application Number
EP10737870A
Filing Date
Jul 23, 2010
Status
Revoked
Apr 30, 2021
Publication Date
Jan 21, 2015
External Links
Slate, Register , Google Patents